MPM Asset Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-313,136
| Closed | -$3.56M | – | 7 |
|
|
2023
Q4 | $3.56M | Hold |
313,136
| – | – | 1.75% | 7 |
|
|
2023
Q3 | $1.26M | Sell |
313,136
-3
| -0% | -$22 | 0.68% | 7 |
|
|
2023
Q2 | $2.22M | Hold |
313,139
| – | – | 1.09% | 7 |
|
|
2023
Q1 | $2.33M | Hold |
313,139
| – | – | 0.97% | 8 |
|
|
2022
Q4 | $2.27M | Hold |
313,139
| – | – | 0.95% | 8 |
|
|
2022
Q3 | $3.04M | Hold |
313,139
| – | – | 1.16% | 8 |
|
|
2022
Q2 | $5.98M | Hold |
313,139
| – | – | 2.52% | 8 |
|
|
2022
Q1 | $15.6M | Hold |
313,139
| – | – | 5.32% | 7 |
|
|
2021
Q4 | $23.6M | Hold |
313,139
| – | – | 5.11% | 7 |
|
|
2021
Q3 | $24.7M | Buy |
313,139
+112
| +0% | +$11.3K | 5.73% | 8 |
|
|
2021
Q2 | $43.4M | Sell |
313,027
-10,804
| -3% | -$2.06M | 8.07% | 6 |
|
|
2021
Q1 | $67.7M | Sell |
323,831
-128,612
| -28% | -$25.8M | 13.09% | 5 |
|
|
2020
Q4 | $75.2M | Hold |
452,443
| – | – | 10.63% | 6 |
|
|
2020
Q3 | $76.9M | Hold |
452,443
| – | – | 14.33% | 5 |
|
|
2020
Q2 | $75.1M | Hold |
452,443
| – | – | 22.35% | 2 |
|
|
2020
Q1 | $52.4M | Hold |
452,443
| – | – | 31.87% | 1 |
|
|
2019
Q4 | $66.9M | Hold |
452,443
| – | – | 29.45% | 1 |
|
|
2019
Q3 | $61.8M | Hold |
452,443
| – | – | 26.45% | 2 |
|
|
2019
Q2 | $58.8M | Hold |
452,443
| – | – | 23.77% | 2 |
|
|
2019
Q1 | $42.8M | Buy |
+452,443
| New | +$59.5M | 17.67% | 3 |
|
MPM Asset Management's HARP Position: Q1 2024 in Review
MPM Asset Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 313,136 shares — an estimated $3.56M sold.
MPM Asset Management first reported a position in HARP in Q1 2019 and held it in 20 quarters. The position peaked at $76.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.
- MPM Asset Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- MPM Asset Management sold 313,136 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.56M.
- MPM Asset Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 20 quarters.
- MPM Asset Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $76.9M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.
Based on MPM Asset Management's 13F filing for Q1 2024, filed 15 May 2024.